Frontlight ResearchEarly access
Trial site
Ark Clinical Research
- 7running trials
- 2closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Fatty liver disease (MASLD/MASH)4 trials
- Type 2 diabetes4 trials
- Obesity3 trials
- Liver cirrhosis1 trial
- Phase
- Phase 35 trials
- Phase 24 trials
- Status
- Recruiting4 trials
- Active, not recruiting2 trials
- Completed2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Boehringer Ingelheim3 trials
- Novo Nordisk A/S3 trials
- Biomea Fusion Inc.1 trial
- GlaxoSmithKline1 trial
- Pfizer1 trial
Running trials
Not yet recruiting
Recruiting
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
Recruiting
Active, not recruiting
A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity
Active, not recruiting
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Type 2 diabetes3 recruiting
- Fatty liver disease (MASLD/MASH)2 recruiting
- Liver cirrhosis1 recruiting
Closed trials
Completed
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026